Emergent BioSolutions (EBS) Retained Earnings (2010 - 2026)

Emergent BioSolutions' Retained Earnings history runs 17 years deep, the most recent figure standing at -$153.0 million for Q1 2026.

• In Q1 2026, Retained Earnings fell 2408.2% year-over-year to -$153.0 million; the TTM figure through Mar 2026 stood at -$153.0 million (down 2408.2% YoY), while the FY2025 annual figure was -$7.5 million, up 96.47% from the prior year.
• Retained Earnings was -$153.0 million for Q1 2026 at Emergent BioSolutions, down from -$7.5 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $738.7 million in Q4 2022 to a low of -$212.4 million in Q4 2024.
• Historically, Retained Earnings has averaged $25.4 million across 5 years, with a median of -$6.1 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Retained Earnings jumped 4849.18% in 2023, then plunged 3626.32% in 2024.
• A 5-year view of Retained Earnings shows it stood at $738.7 million in 2022, then tumbled by 100.77% to -$5.7 million in 2023, then slumped by 3626.32% to -$212.4 million in 2024, then jumped by 96.47% to -$7.5 million in 2025, then slumped by 1940.0% to -$153.0 million in 2026.
• The last three Retained Earnings figures came in at -$153.0 million (Q1 2026), -$7.5 million (Q4 2025), and -$7.5 million (Q3 2025), per Business Quant data.